JAPFA signed a 3-year contract in October 2024 to sell 10 poultry vaccines into Pakistan via UMEX in Karachi. The deal is small — about USD 1M total revenue over 3 years, flat year-on-year. The legal scaffolding is genuinely below JAPFA's 40-article standard template: this is a 22-article variant where the missing 18 articles are exactly the JAPFA protections. The dispute clause (Art. 24) says two opposite things in two paragraphs — "Indonesian courts have exclusive jurisdiction" AND "SIAC arbitration is mandatory." Both cannot be true. The payment clause is one sentence. Indemnity flows only one way (UMEX → JAPFA, not back). MA transfer-back has no teeth.
⚠️ Amendment No. 1 fixes 80% of issues; score moves from 52/F to ~80/B. Send within 30 days.JAPFA signed a 3-year contract in October 2024 to sell 10 poultry vaccines into Pakistan via UMEX Biopharma in Karachi. The deal is small — about USD 1M total revenue over 3 years, flat year-on-year. UMEX pays for DRAP product registration and bears marketing costs; Indonesia governs the contract.
The single most important thing JAPFA needs to know: The dispute clause (Article 24) says two opposite things in two paragraphs — "Indonesian courts have exclusive jurisdiction" AND "SIAC arbitration is mandatory." Both cannot be true. If UMEX defaults on payment or refuses to transfer the DRAP registration back, JAPFA could spend 6-12 months fighting just about which forum hears the case before getting to the merits.
Bottom line: The deal is too small (~USD 1M) to abandon, and the commercial substance is fine. But the legal scaffolding is genuinely below JAPFA template — a 22-article variant where the missing 18 articles are exactly the JAPFA protections. Amendment No. 1 fixes 80% of the issues; the score moves from 52/F to ~80/B.
24(b): "The Parties accept and agree that the courts of Indonesia shall have the exclusive jurisdiction over the matters relating to this Agreement."
24(c): "…settle a dispute by Arbitration in accordance with the Arbitration Rules of the Singapore International Arbitration Centre."
The contract picks Indonesian courts as the exclusive forum AND requires Singapore arbitration. These cannot both be true. SIAC is the Singapore arbitration institution; an Indonesian court is a different thing entirely. If a dispute happens tomorrow, the side that doesn't want to be there can stall for 6-12 months arguing about which forum should hear the case before either side reaches the actual merits.
"the aggrieved Party shall have the right to terminate this Agreement forthwith" — but no express waiver of KUHPerdata Articles 1266 and 1267.
KUHPerdata 1266 and 1267 are Indonesian Civil Code articles — under default Indonesian law, you cannot terminate a contract without going to court first; a one-line waiver clause fixes it. Even though Art. 2(c) says "you can terminate forthwith," in real life you cannot — you must first file suit in Indonesian court (Pengadilan Negeri Jakarta) and get a judge's permission. That takes 12-18 months. While you wait, the counterparty keeps operating under the contract.
"Payments for the Products are made by the Distributing Company to the Supplier in United States Dollars."
That single sentence is the entire payment clause. There is no advance payment, no Letter of Credit (LC), no Net-30 / Net-60 terms, no late-payment interest, no FX-risk allocation. Pakistan has tight FX controls — the State Bank of Pakistan only releases USD against documented imports, with 180-day repatriation rules. If UMEX cannot get USD allocated by SBP, JAPFA has already shipped product with no enforceable payment timeline and no recourse.
"The Distributing Company agrees to indemnify and hold harmless the Supplier and its directors, employees, agents, owners…"
Indemnification means who pays if something goes wrong. UMEX indemnifies JAPFA. JAPFA does NOT indemnify UMEX. So if a JAPFA vaccine batch is genuinely defective and causes flock loss to a Pakistani poultry farmer, UMEX gets sued by the farmer, UMEX cross-claims against JAPFA, and JAPFA has no contractual liability cap. The market standard for vet biological distribution is a mutual indemnity with a 12-month-net-sales cap and an exclusion for indirect / consequential damages (downstream losses like lost profit).
"…shall agree to transfer the rights of the registration to the Supplier, free of cost, upon termination of this Agreement."
The principle is right — UMEX must give the DRAP marketing authorisation (the regulatory permit to sell the vaccine) back at termination. But there is no deadline. No obligation to sign DRAP forms. No promise to cooperate with whoever JAPFA picks as the next Pakistani importer. In Pakistan, DRAP requires the registration to be held by a local Pakistani importer with a Form-8 import license — JAPFA cannot simply "receive" the registration. If UMEX drags its feet, JAPFA loses Pakistan market access for 6-12 months while a new agent registers from scratch.
"…war, dispute, riot, blockade, earthquake, quarantine, restriction, civil disturbance…"
Force majeure means what counts as an excuse for not delivering or not paying. Pakistan has experienced FX crises and could again. Without carve-outs, UMEX could invoke force majeure to walk away from payment obligations any time SBP restricts USD allocation. Conversely, if Pakistan blocks Indonesian vet imports, JAPFA needs FM to cover that as an excuse. The standard fix is asymmetric: JAPFA can invoke FM, UMEX cannot for "economic hardship" or "FX non-availability."
Mr. Ammar Malik signed alone as Director — no co-signature, no company seal, no attached board resolution.
Under Pakistan Companies Act 2017 §172, this is a known soft spot — UMEX could later say "Mr. Malik exceeded his authority" and disavow the contract. Even if Mr. Malik did have the authority, the absence of board documentation makes it easy for a successor to deny ratification.
No compliance representations of any kind.
Pakistan was on the FATF (global anti-money-laundering body) grey list from 2018 to October 2022. There's no contractual representation requiring UMEX to confirm compliance with FCPA (US anti-bribery law), UK Bribery Act, Indonesian Tipikor (anti-corruption law), OFAC sanctions (US sanctions list), or annual screening. If something goes wrong on UMEX's side (a facilitation payment to DRAP, a customs bribe), JAPFA has no contractual remedy and bears the reputational damage.
| # | Issue | Negotiability | What to say in meeting |
|---|---|---|---|
| 1 | Art. 24 dispute contradiction — strike clause (b); SIAC Singapore + 3 arbs + English | High | "Our legal team flagged that Art. 24 says two different things. Let's clean it up — keep Indonesia law, keep SIAC Singapore." |
| 2 | KUHPerdata 1266/1267 waiver | High | "This is a one-liner that both sides actually want — without it, neither party can terminate cleanly under Indonesian law." |
| 3 | Payment / LC structure — 30/70 LC at sight | Medium | "Given Pakistan's FX regime, an LC protects both of us. We accept any State Bank-licensed Pakistani bank as issuer." |
| 4 | Reciprocal indemnity + 12-month cap | Medium | "Right now if a product issue happens, only one side has protection. Let's make it mutual with a fair cap." |
| 5 | MA / DRAP transfer-back deadline — 60 days + LD | High | "If we ever part ways, we both need certainty around the DRAP registration timeline." |
| 6 | Annex 2 escalator + tiered discounts — 10% YoY + 0/2/4% tiers | High | "Let's add a discount structure that rewards UMEX for growth — and gives us both predictable annual growth." |
| 7 | FM narrowing — add carve-outs | High | "We want to exclude economic hardship and FX non-availability so neither side can game force majeure." |
| 8 | Compliance reps — full FCPA / sanctions / FATF block | High | "Standard requirement from our banks — they need to see these in the contract." |
| 9 | Bahasa Indonesia counterpart — bilingual + English prevails | High | "Indonesian law requires it; we'll handle translation." |
| 10 | Confidentiality survival — 5 years post-term | High | (No discussion needed — standard.) |
Why 52/F: The legal scaffolding is genuinely below JAPFA template — a 22-article variant where the missing 18 articles are exactly the JAPFA protections. The dispute clause contradicts itself, the payment clause is one sentence, indemnity flows one way only, and MA transfer-back has no teeth.
Post-Amendment No. 1 projected score: Amendment No. 1 fixes 80% of the issues; score moves from 52/F → ~80/B.